4.5 Article

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Billions spent on rare diseases

Jennifer Rohn

NATURE BIOTECHNOLOGY (2013)

Article Multidisciplinary Sciences

A call for transparent reporting to optimize the predictive value of preclinical research

Story C. Landis et al.

NATURE (2012)

Editorial Material Clinical Neurology

Choosing the right clinical outcome measure: From the patient to the statistician and back

Eugenio Mercuri et al.

NEUROMUSCULAR DISORDERS (2011)

Article Clinical Neurology

Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy

Raffaella Willmann et al.

NEUROMUSCULAR DISORDERS (2010)

Review Medicine, General & Internal

Interventions for muscular dystrophy: molecular medicines entering the clinic

Kate Bushby et al.

LANCET (2009)

Review Clinical Neurology

Design, power, and interpretation of studies in the standard murine model of ALS

Sean Scott et al.

AMYOTROPHIC LATERAL SCLEROSIS (2008)